retatrutide lancet Shows Metabolic Benefits in Phase 3 Studies Retatrutide: The Triple Agonist That

As oral but not intraperitoneal glucose administration stimulates the parasympathetic aspects of the gut-brain axis to centrally mediate hepatic glucose production (168), these findings suggest that INSL-5 may influence glucose homeostasis via direct actions on hepatocytes to influence hepatic gluconeogenesis

Although this topic is reviewed in detail by another article within this themed issue (Hlscher, 2021), we would like to briefly consider the following points

The Trustpilot record reflects attentive complaint handling

Patients enrolled in the trial had biopsy proven NASH/borderline NASH (NAS 4) without cirrhosis (n = 283)